DAPTACEL

This brand name is authorized in United States

Active ingredients

The drug DAPTACEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid
UNII IRH51QN26H - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Diphtheria toxoid
2 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
3 Pertussis, purified antigen
UNII F4TN0IPY37 - BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)
Read about Pertussis, purified antigen
4 Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Pertussis, purified antigen
UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
Read about Pertussis, purified antigen
6 Pertussis, purified antigen
UNII 1O0600285A - BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
Read about Pertussis, purified antigen

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 49281-286

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈